Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4SCAR T Cells in Autoimmune Diseases
NCT05459870Phase 2Not yet recruiting
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Start
- Jun 2027
- Primary completion
- Dec 2029
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of 4SCAR19 in autoimmune disease, sponsored by Shenzhen Geno-Immune Medical Institute. Planned start Jun 2027; status: not yet recruiting.
02
Drugs
4SCAR19
03
Conditions
autoimmune disease
Beyond the preview
Go deeper on NCT05459870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05459870.